Pasithea Therapeutics Cor...

NASDAQ: KTTA · Real-Time Price · USD
0.71
0.01 (1.04%)
At close: Aug 15, 2025, 2:18 PM

Pasithea Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-13.9M -15.51M -13.94M -2.17M
Depreciation & Amortization
18.86M 648.45K 32.37K 1.38K
Stock-Based Compensation
773.69K 592.27K 835.06K 471.25K
Other Working Capital
-1.52M 1.57M -831.78M -329.44K
Other Non-Cash Items
77.81K -732.57K -1.07M 750K
Deferred Income Tax
n/a n/a n/a -2.33M
Change in Working Capital
-1.52M 1.57M -138.44K 111.23K
Operating Cash Flow
-13.92B -13.43M -14.56M -3.17M
Capital Expenditures
n/a -34.3K -2.14M -21.5K
Cash Acquisitions
n/a n/a 77.06K n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a 433.31K -626.9K n/a
Investing Cash Flow
n/a 399.01K -2.06M -21.5K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a -3.73M -3.21M n/a
Dividend Paid
-359.66M n/a n/a n/a
Other Financial Acitivies
4.88B n/a -3.21K 5.69M
Financial Cash Flow
4.52B -3.73M -3.21M 55.93M
Net Cash Flow
-9.41B -16.76M -19.82M 52.72M
Free Cash Flow
-13.92B -12.85M -16.7M -3.2M